Orange Book product · Brand (NDA)
APONVIE
APREPITANT
At a glance
Sep 16, 2022
Approved
Brand (NDA)
Application
Not listed
TE code
14
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 16, 2022
3 yr 10 mo ago
Today
Patent 10500208 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 10624850 expires
Listed method-of-use patent (U-3440) expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 10953018 expires
Listed method-of-use patent (U-3440) expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 11173118 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 11744800 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 11878074 expires
Listed method-of-use patent (U-3787) expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 12115254 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 12115255 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 12290520 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 9561229 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 9808465 expires
Listed method-of-use patent (U-3440) expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 9974742 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 9974793 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Patent 9974794 expires
Listed drug product patent expiration.
Sep 18, 2035
in 9 yr 5 mo
Pharmaceutical detail
Active ingredient
APREPITANT
Strength
32MG/4.4ML (7.2MG/ML)
Dosage form
EMULSION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 216457
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2017CINVANTIBrand (NDA)
NDA 209296 · HERON THERAPS INC
- 2015EMENDBrand (NDA)
NDA 207865 · MSD MERCK CO
- 2006EMENDBrand (NDA)
NDA 021549 · MSD
- 2026APREPITANTGeneric (ANDA)
ANDA 218851 · MYLAN
- 2020APREPITANTGeneric (ANDA)
ANDA 211835 · TORRENT
- 2017APREPITANTGeneric (ANDA)
ANDA 207777 · GLENMARK SPECLT
- 2012APREPITANTGeneric (ANDA)
ANDA 090999 · SANDOZ
Listed patents (14)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10500208 | Sep 18, 2035 | in 9 yr 5 mo | Product |
| 10624850 | Sep 18, 2035 | in 9 yr 5 mo | U-3440 |
| 10953018 | Sep 18, 2035 | in 9 yr 5 mo | U-3440 |
| 11173118 | Sep 18, 2035 | in 9 yr 5 mo | Product |
| 11744800 | Sep 18, 2035 | in 9 yr 5 mo | ProductU-3690 |
| 11878074 | Sep 18, 2035 | in 9 yr 5 mo | U-3787 |
| 12115254 | Sep 18, 2035 | in 9 yr 5 mo | Product |
| 12115255 | Sep 18, 2035 | in 9 yr 5 mo | Product |
| 12290520 | Sep 18, 2035 | in 9 yr 5 mo | Product |
| 9561229 | Sep 18, 2035 | in 9 yr 5 mo | ProductU-3440 |
| 9808465 | Sep 18, 2035 | in 9 yr 5 mo | U-3440 |
| 9974742 | Sep 18, 2035 | in 9 yr 5 mo | Product |
| 9974793 | Sep 18, 2035 | in 9 yr 5 mo | Product |
| 9974794 | Sep 18, 2035 | in 9 yr 5 mo | ProductU-3440 |
